Since 2017, Sahlgrenska Science Park awards the Arvid Carlsson Award every year in September. The aim is to pay tribute to innovation, knowledge and competence in conjunction with good entrepreneurship through an award in Nobel Prize winner Arvid Carlsson’s name.
The award for 2019 is now closed for nominations.
Who can get the award?
Nominated entrepreneurs in life science who drive development for human health and wellbeing.
The ambition is to give recognition and honor to promising and future entrepreneurs in academia, healthcare and industry to stimulate continued learning and networking in the global arena that is life science. Arvid Carlsson, who was awarded the Nobel Prize in medicine in 2000 for his ” ”for discoveries concerning signal transduction in the nervous system” is also the founder of A. Carlsson Research, at Sahlgrenska Science Park.
”I am very happy and proud to give name to an award that strengthens and praises innovation and entrepreneurship while emphasizing the importance of constant competence development,” said Arvid Carlsson when the award was founded.
What does the prize consist of ?
In addition to honors and diplomas, the prize consists of a challenge prize as well as participation in an international conference including travel and accommodation. Lessons learned from the conference will be described afterwards in conjunction with a lecture for entrepreneurs and companies at Sahlgrenska Science Park.
The jury consists of the Board of Sahlgrenska Science Park which represents the business community, University of Gothenburg, Sahlgrenska University Hospital, Chalmers University of Technology, Västra Götaland Region, Business Region Gothenburg and Mölndal City.
This year, the prize will be awarded on September 26, 2019 in conjunction with Park Annual by Sahlgrenska Science Park, organized for the 14th consecutive year.
About Nobel Prize winner Arvid Carlsson
Arvid Carlsson, born 1923, was awarded the Nobel Prize in medicine for ”discoveries concerning signal transduction in the nervous system ” in 2000. Among other things, he studied the neurotransmitters dopamine and serotonin. He shared the award with the Americans Paul Greengard and Eric R. Kandel. Arvid Carlsson’s research led to the recognition that Parkinson’s disease is caused by dopamine deficiency in some parts of the brain and subsequently to the production of Levodopa, an effective drug against this disease. Read more about Arvid Carlsson and the Nobel Prize here.
Arvid Carlsson is a true inspiration and entrepreneur in our environment, and his work has not only been crucial in research and medicine but he is still driven by curiosity and ambition to solve major health problems.”
Charlotta Gummeson, CEO of Sahlgrenska Science Park